LONDON — An ingredient in cannabis called cannabidiol or CBD has shown promise in a clinical trial as a potential new treatment for psychosis, scientists said on Friday. Scientists conducted a small trial of people with psychosis and found patients treated with CBD had lower levels of psychotic … Read More
The post Cannabis ingredient holds promise as anti-psychotic medicine appeared first on Dagga Magazine.